From: Eugene.Leitl@lrz.uni-muenchen.de
Date: Tue Nov 28 2000 - 11:11:03 PST
Grlygrl201@aol.com writes:
> successful pathogens keep the host alive for as long as possible. in this
> respect ebola is a loser. wondering if pharm research will concentrate its
> efforts on diseases with the longest sustainable dependence on drugs.
Are you crazy? Pharma never did anything else. You think HIV would
have warranted the R&D expediture if it had remained a classical 3rd
world disease? Fat chance. Now of course this doesn't mean the stuff
already developed won't be applied in Central Africa -- after
adjusting the therapy costs. Can hardly charge a few kilobucks a day
down there, can they?
This archive was generated by hypermail 2b29 : Tue Nov 28 2000 - 11:18:24 PST